P. Lynch

发表

Clinical and economic benefits of integrated pump/CGM technology therapy in patients with type 1 diabetes in Colombia.

R. Alfonso-Cristancho, S. Roze, A. Gomez, 2016, Endocrinologia y nutricion : organo de la Sociedad Espanola de Endocrinologia y Nutricion.

Long‐term cost‐effectiveness of Dexcom G6 real‐time continuous glucose monitoring system in people with type 1 diabetes in Australia

S. Roze, T. Jones, A. Palmer, 2022, Diabetic medicine : a journal of the British Diabetic Association.

Long-Term Cost-Effectiveness the Dexcom G6 Real-Time Continuous Glucose Monitoring System Compared with Self-Monitoring of Blood Glucose in People with Type 1 Diabetes in France

P. Benhamou, J. Smith-Palmer, S. Roze, 2020, Diabetes Therapy.

Clinical and economic benefits of integrated pump/CGM technology therapy in patients with type 1 diabetes in Colombia

R. Alfonso-Cristancho, S. Roze, A. Gomez, 2016 .

Project Baiterek: A Patient Access Program to Improve Clinical Outcomes and Quality of Life in Children with Type 1 Diabetes in Kazakhstan.

F. Kaufman, J. Smith-Palmer, W. Valentine, 2015, Value in health regional issues.

Association between Real-Time Continuous Glucose Monitor Use and Diabetes-Related Medical Costs for Patients with Type 2 Diabetes.

M. Paudel, C. Parkin, T. Bancroft, 2022, Diabetes technology & therapeutics.

Long-term Cost-Effectiveness of Dexcom G6 Real-time Continuous Glucose Monitoring Versus Self-Monitoring of Blood Glucose in Patients With Type 1 Diabetes in the U.K.

M. Javanbakht, J. Smith-Palmer, S. Roze, 2020, Diabetes Care.

Evaluation of the Long-Term Cost-Effectiveness of the Dexcom G6 Continuous Glucose Monitor versus Self-Monitoring of Blood Glucose in People with Type 1 Diabetes in Canada

J. Smith-Palmer, S. Roze, J. Isitt, 2021, ClinicoEconomics and outcomes research : CEOR.

Resource utilization with insulin pump therapy for type 2 diabetes mellitus.

Scott W. Lee, A. Riedel, Tim Peoples, 2010, The American journal of managed care.

Improved A1C by switching to continuous subcutaneous insulin infusion from injection insulin therapy in type 2 diabetes: A retrospective claims analysis.

Scott W. Lee, J. Levinson, A. Riedel, 2010, Primary care diabetes.

Cost-Effectiveness of a Real-Time Continuous Glucose Monitoring System Versus Self-Monitoring of Blood Glucose in People with Type 2 Diabetes on Insulin Therapy in the UK

S. Roze, J. Isitt, P. Lynch, 2022, Diabetes Therapy.

A cost-effectiveness analysis of continuous subcutaneous insulin injection versus multiple daily injections in type 1 diabetes patients: a third-party US payer perspective.

M. Minshall, C. Graham, Meaghan St. Charles, 2009, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Cost‐utility of real‐time continuous glucose monitoring versus self‐monitoring of blood glucose and intermittently scanned continuous glucose monitoring in people with type 1 diabetes receiving multiple daily insulin injections in Denmark

S. Roze, R. Pollock, P. Lynch, 2023, Diabetes, obesity & metabolism.

Cost-utility of real-time continuous glucose monitoring versus self-monitoring of blood glucose in people with insulin-treated Type II diabetes in France.

P. Lynch, G. Norman, H. Alshannaq, 2024, Journal of comparative effectiveness research.